Zomedica Corp. — Net Income by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/a303d1ba-8a83-4157-8256-22e153fdbfc2/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-81.9M | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-028450 |
| FY 2024 | $-47.0M | 2024-01-01 – 2024-12-31 | evidence 0001558370-25-002904 |
| FY 2023 | $-6.4M | 2023-01-01 – 2023-12-31 | evidence 0001558370-24-007597 |
| FY 2022 | $-17.0M | 2022-01-01 – 2022-12-31 | evidence 0001558370-23-003899 |
| FY 2021 | $-18.4M | 2021-01-01 – 2021-12-31 | evidence 0001558370-23-003899 |
| FY 2020 | $-16.9M | 2020-01-01 – 2020-12-31 | evidence 0001171843-21-001378 |
| FY 2019 | $-19.8M | 2019-01-01 – 2019-12-31 | evidence 0001171843-20-001304 |
| FY 2018 | $-16.6M | 2018-01-01 – 2018-12-31 | evidence 0001171843-19-001229 |
| FY 2017 | $-8.1M | 2017-01-01 – 2017-12-31 | evidence 0001171843-18-001549 |
| FY 2016 | $-5.7M | 2016-01-01 – 2016-12-31 | evidence 0001171843-18-001549 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).